Its neuroprotective effects have been evaluated in patients with dry AMD [95,96], CNGB3-achromatopsia [97], glaucoma [98], retinitis pigmentosa [5,19,99], and macular telangiectasia type 2 (MacTel 2) [100]. The gene discussed is CNGB3; the disease is dry age related macular degeneration.